Keymed Biosciences Inc. Stock
Stocks
2162
KYG5252B1023
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Hong Kong S.E.
07:55:00 18/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 71.65 HKD | -1.78% |
|
-1.85% | +34.14% |
| Market Cap | 18.37B 21.49B 2.74B 2.39B 2.26B 2.05B 3.83B 262B 3.85B 26.89B 10.4B 133B 10.29B 10.06B 427B | P/E 2026 * |
19.5x | P/E 2027 * | 1,283x |
|---|---|---|---|---|---|
| Enterprise Value | 16.99B 19.88B 2.53B 2.21B 2.09B 1.9B 3.54B 243B 3.56B 24.88B 9.62B 123B 9.52B 9.31B 395B | EV / Sales 2026 * |
10.1x | EV / Sales 2027 * | 8.12x |
| Free-Float |
74.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2162 | Delayed | |
Tradegate
| 64Z | Real-time | |
|
Deutsche Boerse AG
| 64Z | Delayed |
| 1 day | -1.71% | ||
| 1 week | -1.85% | ||
| Current month | -4.46% | ||
| 1 month | -8.14% | ||
| 3 months | +24.70% | ||
| 6 months | +33.27% | ||
| Current year | +34.14% |
| 1 week | 71.4 |  | 76 |
| 1 month | 71 | | 84.3 |
| Current year | 44.66 | | 89.75 |
| 1 year | 44.66 | | 89.75 |
| 3 years | 26.6 | | 89.75 |
| 5 years | 16.9 | | 89.75 |
| 10 years | 16.9 | | 89.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bo Chen
CEO | Chief Executive Officer | 52 | 23/04/2018 |
Changyu Wang
PRN | Corporate Officer/Principal | 61 | 03/03/2021 |
Pak Yu Tam
SEC | Corporate Secretary | - | 29/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Bo Chen
CHM | Chairman | 52 | 23/04/2018 |
Changyu Wang
BRD | Director/Board Member | 61 | 03/03/2021 |
Gang Xu
BRD | Director/Board Member | 52 | 21/06/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 13/06/25 | Moonshot Holdings Ltd.
| Other | Company | 21,600,000 | 7.7216% | |
| 11/06/25 | Moonshot Holdings Ltd.
| Other | Company | 18,800,000 | 6.7206% | |
| 15/09/23 | Moonshot Holdings Ltd.
| Other | Company | 114,500 | 0.0409% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.78% | -1.85% | -6.03% | +30.36% | 2.75B | |
| +1.76% | +3.88% | +46.85% | +101.12% | 69.69B | |
| +2.29% | +1.43% | +38.39% | +77.03% | 61.24B | |
| +1.14% | -2.59% | -14.37% | +365.92% | 26.77B | |
| +2.95% | +2.34% | +0.52% | -12.74% | 24.07B | |
| +1.49% | +7.73% | +26.85% | -15.89% | 20.39B | |
| -0.83% | -9.47% | +174.16% | +295.44% | 15.72B | |
| +3.01% | +1.85% | +44.63% | +168.18% | 14.07B | |
| +2.43% | +4.24% | -2.05% | +847.59% | 13.8B | |
| +1.00% | +0.24% | +28.02% | +203.83% | 12.22B | |
| Average | +1.35% | +0.18% | +33.70% | +206.08% | 26.07B | |
| Weighted average by Cap. | +1.78% | +1.66% | +36.26% | +161.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.68B 1.97B 251M 218M 207M 188M 351M 24.02B 353M 2.46B 952M 12.21B 942M 921M 39.07B | 2.15B 2.51B 320M 279M 264M 240M 448M 30.64B 450M 3.14B 1.21B 15.57B 1.2B 1.18B 49.86B |
| Net income | 672M 787M 100M 87.34M 82.66M 75.1M 140M 9.6B 141M 985M 381M 4.88B 377M 368M 15.62B | -14.18M -16.59M -2.11M -1.84M -1.74M -1.58M -2.96M -202M -2.97M -20.76M -8.03M -103M -7.94M -7.76M -329M |
| Net Debt | -1.38B -1.61B -206M -179M -169M -154M -288M -19.69B -289M -2.02B -781M -10.01B -772M -755M -32.03B | -935M -1.09B -139M -121M -115M -104M -195M -13.35B -196M -1.37B -529M -6.79B -524M -512M -21.73B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | HK$71.65 | -1.78% | 1,236,000 |
| 17/09/26 | HK$72.95 | -0.41% | 1,576,500 |
| 16/09/26 | HK$73.25 | -1.81% | 1,499,000 |
| 15/09/26 | HK$74.60 | -0.47% | 827,039 |
| 14/09/26 | HK$74.95 | +2.60% | 1,262,500 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2162 Stock
Select your edition
All financial news and data tailored to specific country editions
